LILLI GREENBERG: Open Payments
NPI 1437924313 · SALEM, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$799 in 50 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $307 · 2025 $799
Food & beverage: $799
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $341 |
| Amgen Inc. | 15 | $182 |
| UCB, Inc. | 3 | $67 |
| Genentech USA, Inc. | 1 | $33 |
| Janssen Biotech, Inc. | 2 | $29 |
| Actelion Pharmaceuticals US, Inc. | 1 | $26 |
| ANI Pharmaceuticals, Inc. | 1 | $22 |
| PFIZER INC. | 1 | $22 |
| Novartis Pharmaceuticals Corporation | 1 | $22 |
| AstraZeneca Pharmaceuticals LP | 1 | $21 |
Products named: RINVOQ, ENBREL, SKYRIZI, Bimzelx, Gazyva, TREMFYA, OPSUMIT, PURIFIED CORTROPHIN GEL.
Industry payments across OR — which companies pay providers there.
